WAY-262611
Lieferant: ENZO LIFE SCIENCES
BMLWN1100005
BMLWN1100025
ENZOBMLWN1100005EA
148
EUR
ENZOBMLWN1100005
ENZOBMLWN1100025
WAY-262611
WAY-262611
DKK1 inhibitor
Wnt pathway agonist acting via inhibition of Dkk1 with no GSK-3β inhibition. TCF-Luciferase EC50=0.63µM. WAY262611 was able to enhance trabecular bone formation rate in the tibia of OVX rats following oral administration.
Formel:
C₂₀H₂₂N₄ Molecular Weight: 318,4 g/mol |
MDL:
MFCD20527803 CAS-Nummer: 1123231-07-1 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...